There were no differences in adherence between patients with ASCVD and FH (15% for ASCVD vs. 14% for FH, P = 0.70), diabetes vs. no diabetes (18% in diabetes vs. 16% in non-diabetes, P = 0.23), or between patients who had dispensed ≥3 vs. <3 different types of statins prior to initiation of PCSK9 mAbs (16% for ≥3 statins vs. 16% for <3 statins, P = 0.51). The gene discussed is PCSK9; the disease is diabetes mellitus.